Features of the psychological status of patients with isolated and comorbid hypertensive disease and its impact on the quality of life of rural and urban residents
pdf (Українська)

Keywords

артеріальна гіпертензія
тривожність
депресія
якість життя

How to Cite

Katerenchuk, I., & Cherkun , M. (2026). Features of the psychological status of patients with isolated and comorbid hypertensive disease and its impact on the quality of life of rural and urban residents. Therapeutics / Named After Prof. M.M. Berezhnytskyi, 7(1), 23-29. https://doi.org/10.31793/2709-7404.2026.7.1.23

Abstract

Introduction. This article presents the results of our own research on the manifestations
of anxiety and depression in patients with isolated and comorbid hypertension, as well as
their impact on the quality of life of rural and urban residents.
Purpose. To examine the prevalence of anxiety and depression as psychosocial factors in
isolated and comorbid hypertension, and to evaluate their impact on the quality of life of
rural and urban residents.
Materials and Methods. A survey was made among 152 patients, who were divided into
three groups. The first group included patients with isolated hypertension (n = 45), of whom
26 (57.8%) were urban residents and 19 (42.2%) were rural residents. The second group
(n = 68) consisted of patients with hypertension complicated by ischemic heart disease, with an
equal distribution of rural and urban residents 34 (50.0%) ans 34 (50.0%). The third group (n =
39) comprised patients with comorbid hypertension, ischemic heart disease, and type 2 diabetes,
among whom 24 (61.5%) lived in urban areas and 15 (38.5%) in rural areas.
The levels of anxiety and depression were assessed using the Hospital Anxiety and Depression
Scale (HADS), while quality of life was evaluated through self-administered questionnaires followed
by the official version of the “Short Health Status Assessment Questionnaire” MOS SF-36 (2011).
The obtained results were analyzed separately in rural and urban patients with comorbid
hypertension at the beginning of treatment and three months after hospital discharge.
Results. In our study, among patients with isolated hypertension, clinical manifestations
of anxiety and depression were observed in 45.4% of cases, while 55.6% showed no such
symptoms. In group II, the absence of anxiety and depression was noted in a relatively
smaller proportion of patients (44.1%) compared with those who had isolated hypertension.
Anxiety manifestations were detected more frequently, whereas depressive disorders were
present in 5.8% of patients. In group III, a marked reduction in the proportion of patients
without signs of anxiety and depression was observed—only 13.3% among rural residents
and 8.3% among urban residents. Depressive manifestations were clinically pronounced
but did not differ significantly between rural and urban patients. Overall, the presence of
anxiety and depression significantly worsened the quality of life.
Conclusions. The presence of anxiety and depression, which is noted in almost half of rural
and urban residents, negatively affects the clinical course, and the comorbid course of arterial
hypertension causes an increase in the number of patients with severe arterial hypertension.

https://doi.org/10.31793/2709-7404.2026.7.1.23
pdf (Українська)

References

Kjeldsen SE. Hypertension and cardiovascular risk: General aspects. Pharmacol Res. 2018 Mar;129:95-99. Available from: https://doi.org/10.1016/j.phrs.2017.11.003

Timmis A, Townsend N, Gale CP, Torbica A, Lettino M, Petersen SE, Mossialos EA, Maggioni AP, Kazakiewicz D, May HT, De Smedt D, Flather M, Zuhlke L, Beltrame JF, Huculeci R, Tavazzi L, Hindricks G, Bax J, Casadei B, Achenbach S, Wright L, Vardas P; European Society of Cardiology. European Society of Cardiology: Cardiovascular Disease Statistics 2019. Eur Heart J. 2020 Jan 1;41(1):12-85. Available from: https://doi.org/10.1093/eurheartj/ehz859

Mancia G, Cappuccio FP, Burnier M, Coca A, Persu A, Borghi C, Kreutz R, Sanner B. Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension. J Intern Med. 2023 Sep;294(3):251-268. Available from: https://doi.org/10.1111/joim.13678

Trevisol DJ, Moreira LB, Kerkhoff A, Fuchs SC, Fuchs FD. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J Hypertens. 2011 Feb;29(2):179-88. Available from: https://doi.org/10.1097/hjh.0b013e328340d76f

Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo AP, Hering D, López-Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet. 2016 Nov 26;388(10060):2665-2712. Available from: https://doi.org/10.1016/s0140-6736(16)31134-5

Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020 Apr;16(4):223-237. Available from: https://doi.org/10.1038/s41581-019-0244-2

MacLeod KE, Ye Z, Donald B, Wang G. A Literature Review of Productivity Loss Associated with Hypertension in the United States. Popul Health Manag. 2022 Jun;25(3):297-308. Available from: https://doi.org/10.1089/pop.2021.0201

Yazdani Z, Jabalameli S, Ebrahimi A, Raeisi Z. Relationship between metabolic diseases (Diabetes and Hyperlipidemia) with depression in the elderly. J Isfahan Med School. 2022;40(684):647–53. [Google Scholar]. Available from: https://www.sid.ir/paper/1037482/en

Kalin NH. The Critical Relationship Between Anxiety and Depression. Am J Psychiatry. 2020 May 1;177(5):365-367. Available from: https://doi.org/10.1176/appi. ajp.2020.20030305

Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiatry. 2015 Apr;72(4):334-41. doi: 10.1001/jamapsychiatry.2014.2502. Erratum in: JAMA Psychiatry. 2015 Jul;72(7):736. doi: 10.1001/jamapsychiatry.2015.0937. Erratum in: JAMA Psychiatry. 2015 Dec;72(12):1259. Available from: https://doi.org/10.1001/jamapsychiatry.2014.2502

Downloads

Download data is not yet available.